Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Barbara Strzałka-Mrozik
Effects of Intravitreal Ranibizumab on the Untreated Eye and Systemic Gene Expression Profile in Age-Related Macular Degeneration [Corrigendum]
Clinical Interventions in Aging
Medicine
Gerontology
Geriatrics
Related publications
Effect of ARMS2 Gene Polymorphism on Intravitreal Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Early Changes in Retinal Thickness When Using Intravitreal Ranibizumab for Age‐related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
Choroidal Blood Flow After the First Intravitreal Ranibizumab Injection in Neovascular Age-Related Macular Degeneration Patients
Acta Ophthalmologica
Medicine
Ophthalmology
Peripapillary Choroidal Thickness After Intravitreal Ranibizumab Injections in Eyes With Neovascular Age-Related Macular Degeneration
BMC Ophthalmology
Medicine
Ophthalmology
Ranibizumab Versus Verteporfin for Neovascular Age-Related Macular Degeneration
New England Journal of Medicine
Medicine
Focal Macular Electroretinograms After Intravitreal Injections of Bevacizumab for Age-Related Macular Degeneration
Investigative Ophthalmology and Visual Science
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Intravitreal Injection of Ranibizumab Using A pro Re Nata Regimen for Age-Related Macular Degeneration and Vision-Related Quality of Life
Clinical Ophthalmology
Ophthalmology
Ranibizumab in Neovascular Age-Related Macular Degeneration: A 5-Year Follow-Up
Clinical Ophthalmology
Ophthalmology
Ranibizumab Monotherapy in Neovascular Age-Related Macular Degeneration With Pigment Epithelial Detachment
Journal of Clinical & Experimental Ophthalmology